NSIM
GPCR icon

North Star Investment Management’s Structure Therapeutics GPCR Stock Holding History

North Star Investment Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.9K Hold
330
– – ﹤0.01% 936
2025
Q4 		$23K Hold
330
– – ﹤0.01% 822
2025
Q3 		$9.24K Hold
330
– – ﹤0.01% 925
2025
Q2 		$6.84K Hold
330
– – ﹤0.01% 956
2025
Q1 		$5.71K Hold
330
– – ﹤0.01% 959
2024
Q4 		$8.95K Sell
330
-650
-66% -$23.1K ﹤0.01% 888
2024
Q3 		$43K Hold
980
– – ﹤0.01% 627
2024
Q2 		$38.5K Buy
980
+100
+11% +$4.11K ﹤0.01% 633
2024
Q1 		$37.7K Hold
880
– – ﹤0.01% 653
2023
Q4 		$35.9K Hold
880
– – ﹤0.01% 643
2023
Q3 		$44.4K Buy
+880
New +$28.4K ﹤0.01% 609

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

North Star Investment Management's GPCR Position: Q1 2026 in Review

North Star Investment Management held its Structure Therapeutics (GPCR) position steady in Q1 2026 at 330 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

North Star Investment Management first reported a position in GPCR in Q3 2023 and has held it in 11 quarters since. The position peaked at $44.4K in Q3 2023. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • North Star Investment Management held 330 shares of Structure Therapeutics worth $15.9K as of Q1 2026.
  • North Star Investment Management left its Structure Therapeutics share count unchanged in Q1 2026.
  • Structure Therapeutics made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #936 holding.
  • North Star Investment Management first reported a position in Structure Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • North Star Investment Management's Structure Therapeutics position peaked at $44.4K in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.